Clinical Trial · NCT02233387

PET CT With HX4 in Cervix Cancer

Overview

The aim of this study is: 1. to determine if tumor hypoxia can be accurately visualised with \[18F\]HX4 PET imaging in cervix cancer, 2. to correlate the \[18F\]HX4 PET images with blood and tissue markers, 3. to investigate the quality and optimal timing of \[18F\]HX4 PET images, 4. to compare \[18F\]HX4 PET uptake with \[18F\]FDG PET uptake before and after treatment and 5. analyze correlation with responses

Sponsor

Unknown Organization

Phase

Phase 2

Contacts

Philippe Lambin, prof MD PhD (STUDY_DIRECTOR)

ClinicalTrials.gov

NCT02233387

Drug / Compound

FDG

Isotope(s):

Target(s):

Glucose Transport

Ligand Class: Small Molecules

HX4

Isotope(s):

Target(s):

Hypoxia

Ligand Class: Small Molecules